Jeevan Scientific Technology logo

Jeevan Scientific Technology

JEEVANSCIENTIFICTECHNOLOGYLTD NSE

Key Fundamentals

MicrocapHealthcare TechnologyHealthcare
Market Cap
₹162 Cr
Volatility
Moderate
P/E Ratio
32
EBITDA
₹9.80 Cr
Return on Equity
0.12%
Debt to Equity
0.3
Book Value
₹35.91
EPS
₹0
52W High
₹93.9
52W Low
₹32.85

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 30.2%
  • Company has a low return on equity of -0.01% over last 3 years.
  • Promoter holding has decreased over last 3 years: -8.23%

Growth Rate

Revenue Growth
29.56% higher than 3Y
Net Income Growth
—
Cash Flow Change
248% lower than 3Y
ROE
-104% lower than 3Y
ROCE
-354% lower than 3Y
EBITDA Margin (Avg.)
-7.66% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
10.39
8.06
10.13
11.07
12.88
11.4
12.51
10.06
8.8
12.38
19.07
21.29
18.28
Expenses
8.36
7.46
9.12
10.09
9.65
8.9
10.44
10.44
10.58
10.31
13.84
17
15.33
Operating Profit
2.03
0.6
1.01
0.98
3.23
2.5
2.07
-0.38
-1.78
2.07
5.23
4.29
2.95
OPM %
19.54%
7.44%
9.97%
8.85%
25.08%
21.93%
16.55%
-3.78%
-20.23%
16.72%
27.43%
20.15%
16.14%
Other Income
0.3
0.26
-0.11
0.23
0.11
0.16
0.23
0.15
0.33
0.2
0.14
0.29
0.17
Interest
0.23
0.26
0.15
0.33
0.33
0.45
0.43
0.55
0.54
0.55
0.54
0.41
0.44
Depreciation
1.47
1.43
1.4
1.64
1.51
1.49
1.48
1.77
1.74
1.69
1.6
1.61
1.7
PBT
0.63
-0.83
-0.65
-0.76
1.5
0.72
0.39
-2.55
-3.73
0.03
3.23
2.56
0.98
Tax %
19.05%
-25.3%
-24.62%
-3.95%
31.33%
65.28%
89.74%
-50.59%
-13.67%
66.67%
25.7%
28.52%
11.22%
Net Profit
0.51
-0.61
-0.49
-0.73
1.03
0.25
0.05
-1.26
-3.22
0.01
2.4
1.84
0.87
EPS in Rs
0.34
-0.39
-0.31
-0.47
0.7
0.16
0.07
-0.82
-1.96
-0.06
0.9
0.81
0.27
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
17.39
18.21
20.39
26.13
23.94
46.9
67.79
36.18
39.65
46.84
61.54
71.02
Expenses
15.59
15.01
16.96
20.27
30.02
29.41
51.02
34.82
35.01
39.37
51.74
56.48
Operating Profit
1.8
3.2
3.43
5.86
-6.08
17.49
16.77
1.36
4.64
7.47
9.8
14.54
OPM %
10.35%
17.57%
16.82%
22.43%
-25.4%
37.29%
24.74%
3.76%
11.7%
15.95%
15.92%
20.47%
Other Income
0.37
0.58
0.92
1
2.5
2.39
5.91
1.07
0.67
0.65
0.97
0.8
Interest
1.28
1.54
1.87
2.36
3.04
2.26
0.96
1.04
0.98
1.82
2.04
1.94
Depreciation
0.68
1.23
2.12
3.13
3.92
3.97
3.69
5.07
5.93
6.25
6.64
6.6
PBT
0.21
1.01
0.36
1.37
-10.54
13.65
18.03
-3.68
-1.6
0.05
2.09
6.8
Tax %
104.76%
10.89%
69.44%
18.25%
-18.6%
13.99%
33.78%
-16.58%
-17.5%
-20%
50.72%
—
Net Profit
-0.01
0.9
0.11
1.11
-8.59
11.74
11.94
-3.07
-1.33
0.05
1.03
5.12
EPS in Rs
-0.02
0.97
0.1
0.73
-5.61
7.67
7.8
-1.97
-0.84
0.08
0.58
1.92
Div. Payout %
0%
0%
0%
0%
0%
6.52%
15.38%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.04
9.28
11.46
15.3
15.3
15.3
15.3
15.48
15.48
15.83
19.92
Reserves
-2.27
7.6
10.55
16.53
7.92
19.72
35.28
32.71
32.95
34.11
52.02
Borrowings
11.08
8.45
18.78
18.15
17.95
10.34
12.55
10.1
13.41
20.58
21.28
Other Liabilities
5.56
5.56
8.59
11.32
12.7
20.62
14.75
7.63
6.03
7.77
13.37
Total Liabilities
20.41
30.89
49.38
61.3
53.87
65.98
77.88
65.92
67.87
78.29
107
Fixed Assets
8.67
16.35
28.17
32.59
30.54
27.38
19.07
24.97
26.66
34.55
36.08
CWIP
0
0
0
0
0
0
0
1.9
2.81
4.71
4.71
Investments
0
0
0
0
0
0
0
0
0
0
2.98
Other Assets
11.74
14.54
21.21
28.71
23.33
38.6
58.81
39.05
38.4
39.03
62.82
Total Assets
20.41
30.89
49.38
61.3
53.87
65.98
77.88
65.92
67.87
78.29
107
Figures in ₹ Crores

Cash Flow

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
3.55
-5.62
5.65
4.04
-0.01
4.95
19.56
-6.41
2.89
10.07
0.42
Investing
-3.63
-8.9
-14.35
-7.87
-1.9
-0.8
-1.2
-6.93
-11.53
-15.62
-9.98
Financing
0.23
14.57
9.86
6.08
0.44
-0.13
5.67
-9.54
2.35
5.24
18.83
Net Cash Flow
0.15
0.05
1.17
2.25
-1.47
4.02
24.03
-22.88
-6.29
-0.3
9.26
Free Cash Flow
-0.08
-14.52
-8.7
-3.83
-1.91
4.15
17.33
-14.57
-9.14
-5.96
-7.76
CFO/OP
197
-176
165
69
32
39
153
-269
101
135
5
Figures in ₹ Crores

Ratios

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
152
227
292
205
104
112
40.97
118
113
124
123
Inventory Days
—
—
—
—
—
—
72.11
106
104
156
227
Days Payable
—
—
—
—
—
—
98.78
323
205
305
458
Cash Conversion Cycle
152
227
292
205
104
112
14.3
-99.23
11.85
-25.63
-109
Working Capital Days
52.05
90.6
35.44
-3.07
-101
37.36
10.18
111
137
128
121
ROCE %
—
12.69%
6.75%
8.22%
-16.39%
36.77%
27.58%
-4.34%
-1.03%
2.8%
5.01%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Jeevan Scientific Technology insights

58 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

Public55.80%Others13.95%Promot.30.25%As ofJun 2026

Documents

Frequently Asked Questions about Jeevan Scientific Technology

What does Jeevan Scientific Technology Ltd do?
Incorporated in 1999, Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutions[1]
Where is Jeevan Scientific Technology Ltd (538837) listed?
Jeevan Scientific Technology Ltd trades as JEEVANSCIENTIFICTECHNOLOGYLTD on the NSE and under code 538837 on the BSE.
Which sector does Jeevan Scientific Technology Ltd belong to?
Jeevan Scientific Technology Ltd is classified under the Healthcare sector, in the Healthcare Technology industry.
What is the market capitalisation of Jeevan Scientific Technology Ltd?
Jeevan Scientific Technology Ltd has a market capitalisation of ₹161.73 Cr, which places it in the Small Cap band.
What is the PE ratio of Jeevan Scientific Technology Ltd?
Jeevan Scientific Technology Ltd trades at a PE ratio of 32.00, on earnings per share of ₹0, against a book value of ₹35.91 per share.
What is the 52-week high and low of Jeevan Scientific Technology Ltd?
Over the last 52 weeks Jeevan Scientific Technology Ltd has traded between ₹32.85 and ₹93.9.
Does Jeevan Scientific Technology Ltd pay dividends?
Jeevan Scientific Technology Ltd has a dividend yield of 1.47%.
What is the Return on Equity (ROE) of Jeevan Scientific Technology Ltd?
Jeevan Scientific Technology Ltd reported a return on equity of 0.12%. Its debt-to-equity ratio is 0.30.

Company Information

Incorporated in 1999, Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutions[1]

Website jeevanscientific.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/538837.md for Jeevan Scientific Technology Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List